Largest For-Profit Psych Chain Settles Claims of Child Sexual Abuse at Virginia Hospital—UHS, the largest for-profit psychiatric chain long accused of prioritizing profits over safety (including a 2020 $122M DOJ settlement over unnecessary admissions, excessive stays, and improper restraints, plus repeated reports of patient abuse), reached a tentative settlement in lawsuits alleging its former Cumberland Hospital medical director, Dr. Daniel Davidow, sexually abused young patients by inappropriately touching their breasts and genitals during exams presented as routine medical checks. The defendants deny liability. And yet, UHS has a major history of abuse: CCHR International has investigated UHS since ~2008 and filed 36,000 complaints against it to legislators, law enforcement, the FBI, Attorneys General, U.S. Attorneys, state licensing boards, and other state agencies, documenting a long history of patient abuse and related issues including assaults, restraints, and death, as well as rampant child abuse. See this link: cchrint.org/2020/10/30/child…

Psychiatry’s Response: Attack and PR— “They won’t acknowledge their errors. They won’t back down. And they won’t stop, or even curtail, their destructive practices. They will not even seriously debate the issues. Instead, they’ve gone on the offensive. This offensive is two-pronged. Firstly, they attack those of us who speak out against them, and secondly, they are actively developing links to the media in the hopes that this will encourage reporters to portray them in a more favorable light.” – Philip Hickey, Ph.D., psychologist from his 2014 article, Psychiatry’s Response: Attack and PR

FDA Again Lags Behind UK on Antidepressant Warnings for Suicide Risk and Persistent Sexual Dysfunction —The UK’s drug regulatory agency has expanded suicide risk information to all ages and formally recognizes antidepressant-induced sexual dysfunction. The United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) has announced new antidepressant safety measures for all patients. The changes follow a review prompted by concerns from patients and families and require clearer suicide risk information for patients of all ages—currently limited to children and young adults. For the first time, the measures also recognize that sexual dysfunction, known as Post-SSRI Sexual Dysfunction (PSSD), can occur from certain antidepressants and can continue even after the drugs are stopped. Notably, the MHRA has again acted before the U.S. Food and Drug Administration (FDA). The FDA must issue the same warnings. In December 2003, the MHRA was the first to issue warnings that SSRI antidepressants increased suicide and self-harm risk in young people, brought to their attention by Dr. David Healy, professor of psychiatry at Bangor University in the UK. The FDA had relevant data for decades. In October 2004, almost a year after the MHRA’s warning, the FDA added a black-box warning for suicidal ideation in those 18 and younger, later extended to age 24. This left the implication that the risk ends on a person’s 25th birthday.[6] Dr. Healy, also an expert psychopharmacologist, warned in 2009 that “antidepressants pose a risk of suicide in all age groups,” citing elevated relative risks for completed suicide in ages 18–64 based on FDA trial data. More>> cchrint.org/2026/10/23/fda-a…

👇👇👇

Yet another tragedy as a result of the psychiatric industry. At least 17 psychiatric drugs prescribed to the patient, that didn’t work—he reports that an antidepressant increased his anxiety and obsessive thoughts—he is given electroshock, TMS (transcranial magnetic stimulation), and ketamine across multiple psychiatric facilities, then discharged while expressing suicidal thoughts. Result: death by suicide. This is not an isolated failure. Abuses like this are rampant throughout the mental health industry, which has consistently demonstrated it cannot reform itself and must be held to account. coloradosun.com/2026/10/20/i…

Agreed 🙌🙌 — and long overdue

WHO Report Warns Psychiatric Hospitals Violate Patient Autonomy and Rights, With Nearly Half of Residents Held Involuntarily The new WHO guidelines warn that institutional psychiatric treatment can separate people from their communities, limit their autonomy, and expose them to risks of human rights violations. Nearly half of people living in large psychiatric hospitals and social care institutions are held against their will for months, years, or even decades. More than 1.2 million Americans are involuntarily committed each year. A Harvard School of Public Health study says psychiatric hospitals continue to use forced electroshock, chemical restraints, and prolonged mechanical restraint—practices that violate the United Nations Convention against Torture (UNCAT), which the U.S. has ratified. Despite growing recognition of these harms, the United States is moving in the opposite direction. The American Bar Association has noted that a human rights-centered approach requires shifting away from primarily medicalized responses toward person-centered support, yet “legislative reforms have often become procedural formalities that legitimize restrictive interventions under the guise of legal protection.” These findings underscore the scale of coercive practices still embedded in institutional mental health systems. cchrint.org/2026/10/16/cchr-…

UK Warns All Antidepressant Patients of Suicide Risk and Persistent Sexual Dysfunction—FDA Still Lags; The UK’s MHRA, the country’s drug regulatory agency, is now requiring clearer alerts for all patients on the risk of post-SSRI sexual dysfunction (PSSD) and suicidal thoughts and behaviors. Once again the MHRA has acted while the FDA lags. Back in 2003, it was the MHRA that first warned that SSRIs increased suicide and self-harm risk in young people, despite the FDA having this data for decades. The FDA only followed with its own warnings a year after the MHRA, and even today the black box warning on suicidal ideation extend only to age 24—implying the risk magically disappears on one’s 25th birthday. The UK’s new alerts on suicidal thoughts and behaviors apply to patients of all ages. The FDA has yet to warn on post SSRI sexual dysfunction. gov.uk/drug-safety-update/an…

ADHD drugs are in the same class of highly addictive drugs (DEA schedule 2) as Fentanyl and Oxycontin - and they are handed out to children like candy

"Even in my darkest moments, something deep inside me knew not to take the pill. I remember telling her, “I think Zoloft is what killed my husband. But more importantly, my husband just died. Aren’t I supposed to hurt?”

"For more than three decades, America has normalized the widespread drugging of children and adults under the banner of attention deficit/hyperactivity disorder (ADHD). Yet, ADHD remains a subjective psychiatric label with no objective medical test..." townhall.com/columnists/sher…

With zero accountability for the damage they inflict...

Post SSRI Sexual Dysfunction (PSSD)—patients are never warned this "side effect" can be permanent 👇

There is virtually zero informed consent with these SSRIs.

Post SSRI Sexual Dysfunction (PSSD) is something the FDA must address so patients are fully informed and warned as it's devastating lives